Publication:
Burn Epidemiology and Cost of Medication in Paediatric Burn Patients

dc.authorscopusid36183541900
dc.authorscopusid36183412500
dc.contributor.authorKoç, Zeliha
dc.contributor.authorSağlam, Z.
dc.date.accessioned2020-06-21T14:18:09Z
dc.date.available2020-06-21T14:18:09Z
dc.date.issued2012
dc.departmentOndokuz Mayıs Üniversitesien_US
dc.department-temp[Koç] Zeliha, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Sağlam] Zeynep Selcan, Ondokuz Mayis Üniversitesi, Samsun, Turkeyen_US
dc.description.abstractBurns are common injuries that cause problems to societies throughout the world. In order to reduce the cost of burn treatment in children, it is extremely important to determine the burn epidemiology and the cost of medicines used in burn treatment. The present study used a retrospective design, with data collected from medical records of 140 paediatric patients admitted to a burn centre between 1 January 2009 and 31 December 2009. Medical records were examined to determine burn epidemiology, medication administered, dosage, and duration of use. Descriptive statistical analysis was completed for all variables; chi-square was used to examine the relationship between certain variables. It was found that 62.7% of paediatric burns occur in the kitchen, with 70.7% involving boiling water; 55.7% of cases resulted in third-degree burns, 19.3% required grafting, and mean duration of hospital stay was 27.5 ± 1.2 days. Medication costs varied between $1.38 US dollars (USD) and $14,159.09, total drug cost was $46,148.03 and average cost per patient was $329.63. In this study, the medication cost for burn patients was found to be relatively high, with antibiotics comprising the vast majority of medication expenditure. Most paediatric burns are preventable, so it is vital to educate families about potential household hazards that can be addressed to reduce the risk of a burn. Programmes are also recommended to reduce costs and the inappropriate prescribing of medication. © 2012 Elsevier Ltd and ISBI.en_US
dc.identifier.doi10.1016/j.burns.2012.03.011
dc.identifier.endpage819en_US
dc.identifier.issn0305-4179
dc.identifier.issn1879-1409
dc.identifier.issue6en_US
dc.identifier.pmid22683357
dc.identifier.scopus2-s2.0-84864138608
dc.identifier.scopusqualityQ2
dc.identifier.startpage813en_US
dc.identifier.urihttps://doi.org/10.1016/j.burns.2012.03.011
dc.identifier.volume38en_US
dc.identifier.wosWOS:000307692400006
dc.identifier.wosqualityQ1
dc.language.isoenen_US
dc.publisherElsevier Sci Ltden_US
dc.relation.ispartofBurnsen_US
dc.relation.journalBurnsen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectBurnen_US
dc.subjectCosten_US
dc.subjectEpidemiologyen_US
dc.subjectMedicationen_US
dc.subjectPaediatricen_US
dc.titleBurn Epidemiology and Cost of Medication in Paediatric Burn Patientsen_US
dc.typeArticleen_US
dspace.entity.typePublication

Files